-transparent.png){kind=logo}
Hyperbaric Oxygen Therapy for Carbon Monoxide-Induced Delayed Neuropsychiatric Sequelae: Case Report of Two Cases and Relevant Literature Review. 2021
Akira Monji, and
Hiroshi Tateishi, and
Toru Murakawa, and
Jun Matsushima, and
Yutaka Kunitake, and
Takumi Shiraishi, and
Ryohei Kojima, and
Takayoshi Inaba, and
Takahiro Kato, and
Yoshito Mizoguchi
Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
We herein report two cases with carbon monoxide- (CO-) induced delayed neuropsychiatric sequelae (DNS) successfully treated with hyperbaric oxygen therapy (HBOT) in attempt suicide by charcoal burning. The two patients with CO-induced DNS were successfully treated with a total of more than 100 sessions of HBOT. Frontal assessment battery (FAB) was useful to examine the effectiveness of HBOT objectively. In the future study, a large-randomized trial is required to establish the efficacy of HBOT for the treatment of DNS.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Akira Monji, and
Hiroshi Tateishi, and
Toru Murakawa, and
Jun Matsushima, and
Yutaka Kunitake, and
Takumi Shiraishi, and
Ryohei Kojima, and
Takayoshi Inaba, and
Takahiro Kato, and
Yoshito Mizoguchi
May 2001,
Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
Akira Monji, and
Hiroshi Tateishi, and
Toru Murakawa, and
Jun Matsushima, and
Yutaka Kunitake, and
Takumi Shiraishi, and
Ryohei Kojima, and
Takayoshi Inaba, and
Takahiro Kato, and
Yoshito Mizoguchi
March 2024,
Diving and hyperbaric medicine,
Akira Monji, and
Hiroshi Tateishi, and
Toru Murakawa, and
Jun Matsushima, and
Yutaka Kunitake, and
Takumi Shiraishi, and
Ryohei Kojima, and
Takayoshi Inaba, and
Takahiro Kato, and
Yoshito Mizoguchi
September 2021,
Scientific reports,
Akira Monji, and
Hiroshi Tateishi, and
Toru Murakawa, and
Jun Matsushima, and
Yutaka Kunitake, and
Takumi Shiraishi, and
Ryohei Kojima, and
Takayoshi Inaba, and
Takahiro Kato, and
Yoshito Mizoguchi
May 1992,
Harefuah,
Akira Monji, and
Hiroshi Tateishi, and
Toru Murakawa, and
Jun Matsushima, and
Yutaka Kunitake, and
Takumi Shiraishi, and
Ryohei Kojima, and
Takayoshi Inaba, and
Takahiro Kato, and
Yoshito Mizoguchi
February 1991,
The New Zealand medical journal,
Akira Monji, and
Hiroshi Tateishi, and
Toru Murakawa, and
Jun Matsushima, and
Yutaka Kunitake, and
Takumi Shiraishi, and
Ryohei Kojima, and
Takayoshi Inaba, and
Takahiro Kato, and
Yoshito Mizoguchi
November 2021,
The Journal of emergency medicine,
Akira Monji, and
Hiroshi Tateishi, and
Toru Murakawa, and
Jun Matsushima, and
Yutaka Kunitake, and
Takumi Shiraishi, and
Ryohei Kojima, and
Takayoshi Inaba, and
Takahiro Kato, and
Yoshito Mizoguchi
January 2010,
Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc,
Akira Monji, and
Hiroshi Tateishi, and
Toru Murakawa, and
Jun Matsushima, and
Yutaka Kunitake, and
Takumi Shiraishi, and
Ryohei Kojima, and
Takayoshi Inaba, and
Takahiro Kato, and
Yoshito Mizoguchi
January 2019,
Journal of the neurological sciences,
Akira Monji, and
Hiroshi Tateishi, and
Toru Murakawa, and
Jun Matsushima, and
Yutaka Kunitake, and
Takumi Shiraishi, and
Ryohei Kojima, and
Takayoshi Inaba, and
Takahiro Kato, and
Yoshito Mizoguchi
October 2019,
Brain sciences,
Akira Monji, and
Hiroshi Tateishi, and
Toru Murakawa, and
Jun Matsushima, and
Yutaka Kunitake, and
Takumi Shiraishi, and
Ryohei Kojima, and
Takayoshi Inaba, and
Takahiro Kato, and
Yoshito Mizoguchi
July 2023,
Cureus,
